Navigation Links
Asmanex Twisthaler launched by Schering-Plough for treatment of asthma

Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in patients 12 years of age and older. It was launched in the United Kingdom in January and is expected to be launched in the other European Union(EU) markets, in the next few months. Asmanex Twisthaler, a dry powder inhaler, contains the orally// inhaled corticosteroid mometasone furoate, which was discovered and developed by Schering-Plough Research Institute. The product employs a state-of-the-art, inhalation-driven device that does not use a propellant, thus eliminating the need for hand-breath coordination.

Asmanex Twisthaler represents a major new treatment option in helping asthma patients manage their disease and is a valuable addition to the therapies available to physicians for treating asthma, which is a serious and life-threatening disease. Richard Jay Kogan, President and CEO of Schering-Plough said that Asmanex, which is the first asthma therapy in international markets, represents an important advance for Schering-Plough and will significantly strengthen its respiratory portfolio, which includes Nasonex, an inhaled nasal steroid for allergies, and Clarinex, the once-daily non-sedating antihistamine. The Chairman, Hans-Jorg Kummer, added that the product's proven efficacy, convenient once-daily dosing and easy-to-use device would help patients better adhere to their dosing regimen and assist in achieving control of their asthma symptoms.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. New initiative launched to fight malaria by repelling mosquitoes
3. Clarithromycin tablets to be launched in India soon
4. Guide for physicians launched to help them identify alcohol disorders
5. New X-ray machine launched by GE Healthcare
6. Historic trial for tuberculosis launched together by leading drug companies
7. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
8. Hot Air Balloon Festival launched in Rajasthan
9. Thyroid hormone treatment hastens recovery after cardiac surgery
10. Feeding channel created by malaria parasite - a new target for malaria treatments
11. Now umbilical cord helps in stroke treatment.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... 23, 2016 Leading BioSciences Inc., a ... conditions resulting from a breakdown of the mucosal ... Greg Doyle as chief executive officer. Mr. ... management team and board of directors, previously served ... He will provide continued leadership and strategic direction ...
Breaking Medicine Technology: